Dr. Agarwal's Health Care Officially Ends Idearx Services Associate Status

Dr. Agarwal's Health Care has officially announced the cessation of Idearx Services Private Limited as an associate company, following the termination of their shareholders' agreement effective March 30, 2026.

Regulatory Disclosure Details

The company filed a regulatory disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, confirming the formal end of its associate relationship with Idearx Services. This disclosure follows an earlier announcement made on February 03, 2026, regarding proposed amendments to the shareholders' agreement.

Parameter: Details Effective Date: March 30, 2026 Regulation: SEBI Regulation 30 Associate Status: Ceased Retained Equity: 14.54% BSE Scrip Code: 544350 NSE Symbol: AGARWALEYE

Agreement Amendment Impact

Pursuant to amendments in both the shareholders' agreement and Idearx's Articles of Association, Dr. Agarwal's Health Care's rights under the original shareholders' agreement have been terminated. The healthcare services provider confirmed that Idearx Services no longer qualifies as an 'Associate' under regulatory definitions.

Continuing Shareholder Rights

Despite the termination of associate status, Dr. Agarwal's Health Care will continue to hold 14.54% of Idearx Services' total equity share capital. The company emphasized that all standard shareholder rights under the Companies Act, 2013, and other applicable laws remain intact.

Strategic Restructuring

This corporate action represents a strategic restructuring move by Dr. Agarwal's Health Care, transitioning from an associate relationship to a standard equity investment position. The measured approach allows the company to maintain financial interest while stepping back from operational collaboration and governance responsibilities associated with associate status.

Dr. Agarwal's Health Care has completed an inter-se transfer of shares between promoter group members, with official regulatory documentation filed on March 23, 2026. Dr. Athiya Agarwal acquired 14,41,568 shares representing 0.455% of the company's total share capital through a gift transaction from Dr. Anosh Agarwal, executed on March 19, 2026.

Official Regulatory Filing

The transaction was formally disclosed through a comprehensive letter dated March 23, 2026, addressed to BSE Limited, National Stock Exchange of India Limited, and the company's compliance officer. The disclosure was made under Regulation 29(2) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Parameter: Details Transaction Date: March 19, 2026 Filing Date: March 23, 2026 Transferor: Dr. Anosh Agarwal Transferee: Dr. Athiya Agarwal Transfer Mode: Inter-se off-market transfer by way of gift Shares Transferred: 14,41,568 Percentage: 0.455%

Shareholding Changes

The regulatory filing provides detailed shareholding information showing Dr. Athiya Agarwal's position before and after the acquisition. Prior to the transaction, Dr. Athiya Agarwal held 1,26,61,975 shares representing 4.00% of the total share capital.

Transaction Phase: Shares Held Percentage Before Acquisition: 1,26,61,975 4.00% Shares Acquired: 14,41,568 0.455% After Acquisition: 1,41,03,543 4.45%

Company Structure and Compliance

Dr. Agarwal's Health Care Limited maintains its equity share capital at 31,68,07,506 equity shares of Re. 1/- each, aggregating to ₹31,68,07,506. The company's shares are listed on both National Stock Exchange of India Limited and BSE Limited.

Company Details: Information Total Equity Shares: 31,68,07,506 Face Value: Re. 1/- each Total Share Capital: ₹31,68,07,506 Listing Exchanges: NSE and BSE

Transaction Characteristics

The share transfer was executed as an inter-se transfer between promoter group members by way of gift among immediate relatives. Both transferor and transferee belong to the promoter/promoter group category, with no monetary consideration involved in the transaction. The transfer was completed through off-market mechanism while maintaining full regulatory compliance with SEBI requirements.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.